236 related articles for article (PubMed ID: 20813060)
21. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.
Flores G; Wood GK; Liang JJ; Quirion R; Srivastava LK
J Neurosci; 1996 Nov; 16(22):7366-75. PubMed ID: 8929443
[TBL] [Abstract][Full Text] [Related]
22. Characterization of dopamine D
Szűcs E; Ducza E; Büki A; Kekesi G; Benyhe S; Horvath G
Brain Res; 2020 Dec; 1748():147074. PubMed ID: 32858029
[TBL] [Abstract][Full Text] [Related]
23. Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders.
Dobbs LK; Lemos JC; Alvarez VA
Genes Brain Behav; 2017 Jan; 16(1):56-70. PubMed ID: 27860248
[TBL] [Abstract][Full Text] [Related]
24. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
Seeman P
Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent.
Mayfield RD; Zahniser NR
Mol Pharmacol; 2001 Jan; 59(1):113-21. PubMed ID: 11125031
[TBL] [Abstract][Full Text] [Related]
26. Capture of D2 dopamine receptor signaling complexes in striatal cells for mass spectrometry proteomic analysis.
Kabbani N; Nordman JC
Methods Mol Biol; 2013; 964():43-60. PubMed ID: 23296777
[TBL] [Abstract][Full Text] [Related]
27. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
28. Alterations in ventral and dorsal striatal allosteric A2AR-D2R receptor-receptor interactions after amphetamine challenge: Relevance for schizophrenia.
Pintsuk J; Borroto-Escuela DO; Lai TK; Liu F; Fuxe K
Life Sci; 2016 Oct; ():. PubMed ID: 27984074
[TBL] [Abstract][Full Text] [Related]
29. Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity.
Vanderschuren LJ; Schoffelmeer AN; Van Leeuwen SD; Hof L; Jonker AJ; Voorn P
Eur J Neurosci; 2002 Dec; 16(12):2462-8. PubMed ID: 12492441
[TBL] [Abstract][Full Text] [Related]
30. Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.
Ramshaw H; Xu X; Jaehne EJ; McCarthy P; Greenberg Z; Saleh E; McClure B; Woodcock J; Kabbara S; Wiszniak S; Wang TY; Parish C; van den Buuse M; Baune BT; Lopez A; Schwarz Q
Transl Psychiatry; 2013 Dec; 3(12):e327. PubMed ID: 24301645
[TBL] [Abstract][Full Text] [Related]
31. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R
Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949
[TBL] [Abstract][Full Text] [Related]
32. Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats.
Zhang S; Xie C; Wang Q; Liu Z
Sci Rep; 2014 Oct; 4():6811. PubMed ID: 25351365
[TBL] [Abstract][Full Text] [Related]
33. Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor.
Purkerson-Parker S; McDaniel KL; Moser VC
Toxicol Sci; 2001 Dec; 64(2):216-23. PubMed ID: 11719704
[TBL] [Abstract][Full Text] [Related]
34. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
Schwendt M; Gold SJ; McGinty JF
J Neurochem; 2006 Mar; 96(6):1606-15. PubMed ID: 16539683
[TBL] [Abstract][Full Text] [Related]
35. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
[TBL] [Abstract][Full Text] [Related]
36. The dopamine transporter: a vigilant border control for psychostimulant action.
Williams JM; Galli A
Handb Exp Pharmacol; 2006; (175):215-32. PubMed ID: 16722238
[TBL] [Abstract][Full Text] [Related]
37. Psychosis pathways converge via D2high dopamine receptors.
Seeman P; Schwarz J; Chen JF; Szechtman H; Perreault M; McKnight GS; Roder JC; Quirion R; Boksa P; Srivastava LK; Yanai K; Weinshenker D; Sumiyoshi T
Synapse; 2006 Sep; 60(4):319-46. PubMed ID: 16786561
[TBL] [Abstract][Full Text] [Related]
38. Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
Gifford AN; Park MH; Kash TL; Herman LM; Park EH; Gatley SJ; Volkow ND
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):413-8. PubMed ID: 11111836
[TBL] [Abstract][Full Text] [Related]
39. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
[TBL] [Abstract][Full Text] [Related]
40. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
Cervinski MA; Foster JD; Vaughan RA
J Biol Chem; 2005 Dec; 280(49):40442-9. PubMed ID: 16204245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
